Food and Drug Administration

Condividi contenuti
Aggiornato: 1 ora 19 min fa

FDA Provides Educational Resources for Parents and Caregivers to Support Confidence for Imported Infant Formula Products

Gi, 14/07/2022 - 15:08
The FDA announced the availability of educational resources for parents and caregivers with questions about using the hundreds of millions of bottles worth of imported infant formula headed to the U.S.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted

Me, 13/07/2022 - 22:10
The FDA issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.
Categorie: Istituzioni

FDA Warns Four Companies for Selling Tainted Honey-based Products with Hidden Active Drug Ingredients

Ma, 12/07/2022 - 16:32
Today, the FDA issued warning letters to four companies for illegally selling honey-based products that may pose a significant health risk to consumers.
Categorie: Istituzioni

FDA Infant Formula Update: July 8, 2022

Ve, 08/07/2022 - 21:18
FDA Infant Formula Update: July 8 (Australia)
Categorie: Istituzioni

FDA Roundup: July 8, 2022

Ve, 08/07/2022 - 20:50
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Developing New Framework for Continued, Expanded Access to Infant Formula Options for U.S. Parents and Caregivers

Me, 06/07/2022 - 20:09
The FDA is developing a new framework for continue and expanded access to infant formula options for U.S. parents and caregivers.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Authorizes Pharmacists to Prescribe Paxlovid with Certain Limitations

Me, 06/07/2022 - 18:35
The FDA revised the EUA for Paxlovid to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid
Categorie: Istituzioni

FDA Infant Formula Update: July 6, 2022

Me, 06/07/2022 - 15:31
FDA Infant Formula Update July 6 Vitaflo (Netherlands)
Categorie: Istituzioni

FDA Roundup: July 5, 2022

Ma, 05/07/2022 - 22:17
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Roundup: July 1, 2022

Ve, 01/07/2022 - 17:53
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Infant Formula Update: June 30, 2022

Gi, 30/06/2022 - 19:36
FDA Infant Formula Update June 30 Danone New Zealand
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses

Gi, 30/06/2022 - 16:05
The FDA has advised manufacturers seeking to update their COVID-19 vaccines that they should develop modified vaccines that add an omicron BA.4/5 spike protein component to the current vaccine composition to create a two component (bivalent) booster vaccine, beginning in Fall 2022.
Categorie: Istituzioni

FDA Roundup: June 28, 2022

Ma, 28/06/2022 - 20:37
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Infant Formula Update: June 28, 2022

Ma, 28/06/2022 - 20:06
FDA Infant Formula Update June 28 Abbott (Ireland)
Categorie: Istituzioni

FDA Introduces Innovative Proposal to Advance Consumer Access to Nonprescription Drugs

Lu, 27/06/2022 - 16:12
Today, the FDA issued a proposal to broaden the range of marketed nonprescription drugs available to consumers.
Categorie: Istituzioni

FDA Infant Formula Update: June 27, 2022

Lu, 27/06/2022 - 15:14
FDA Infant Formula Update June 27 Bellamy (Australia)
Categorie: Istituzioni

FDA Roundup: June 24, 2022

Ve, 24/06/2022 - 21:53
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Releases Action Plan for Rare Neurodegenerative Diseases, Including ALS

Gi, 23/06/2022 - 17:37
The FDA launched the Action Plan for Rare Neurodegenerative Diseases including ALS, outlining the agency’s strategy for improving and extending the lives of people living with these diseases by advancing the development of safe, effective medical products, and by facilitating patient access to novel
Categorie: Istituzioni

FDA Denies Authorization to Market JUUL Products

Gi, 23/06/2022 - 16:27
Today, the U.S. Food and Drug Administration issued marketing denial orders (MDOs) to JUUL Labs Inc. for all of their products currently marketed in the United States. As a result, the company must stop selling and distributing these products.
Categorie: Istituzioni

FDA Infant Formula Update: June 22, 2022

Me, 22/06/2022 - 21:30
FDA exercises enforcement discretion to Global Kosher to import various Kendamil infant formula products from United Kingdom following review of nutritional adequacy and safety information, including microbiological testing, labeling, facility production and inspection history
Categorie: Istituzioni